Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Markus, Möbs"'
Autor:
Josefine Radke, Elisa Schumann, Julia Onken, Randi Koll, Güliz Acker, Bohdan Bodnar, Carolin Senger, Sascha Tierling, Markus Möbs, Peter Vajkoczy, Anna Vidal, Sandra Högler, Petra Kodajova, Dana Westphal, Friedegund Meier, Frank Heppner, Susanne Kreuzer-Redmer, Florian Grebien, Karsten Jürchott, Torben Redmer
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-24 (2022)
Melanoma brain metastases (MBM) show heterogeneous therapeutic response determined by incompletely understood mechanisms. Here, the authors use a multi-OMICS approach and targeted sequencing (TargetSeq) to decipher programs that may define molecular
Externí odkaz:
https://doaj.org/article/5f4425782714454798970d794d958825
Autor:
Alexander Arnold, Moritz Tronser, Christine Sers, Ayel Ahadova, Volker Endris, Soulafa Mamlouk, David Horst, Markus Möbs, Philip Bischoff, Michael Kloor, Hendrik Bläker
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background β-catenin activation plays a crucial role for tumourigenesis in the large intestine but except for Lynch syndrome (LS) associated cancers stabilizing mutations of β-catenin gene (CTNNB1) are rare in colorectal cancer (CRC). Prev
Externí odkaz:
https://doaj.org/article/407566c77f1d4a7485b2fedafcd37fb6
Autor:
Soulafa Mamlouk, Liam Harold Childs, Daniela Aust, Daniel Heim, Friederike Melching, Cristiano Oliveira, Thomas Wolf, Pawel Durek, Dirk Schumacher, Hendrik Bläker, Moritz von Winterfeld, Bastian Gastl, Kerstin Möhr, Andrea Menne, Silke Zeugner, Torben Redmer, Dido Lenze, Sascha Tierling, Markus Möbs, Wilko Weichert, Gunnar Folprecht, Eric Blanc, Dieter Beule, Reinhold Schäfer, Markus Morkel, Frederick Klauschen, Ulf Leser, Christine Sers
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-12 (2017)
The contribution of intra-tumour heterogeneity is increasingly associated with resistance to therapy. Here, the authors use genomic analyses to study heterogeneity in colorectal cancer and perform in-depth reconstruction of heterogeneity in one sampl
Externí odkaz:
https://doaj.org/article/377eccf6acfe4e04830ad0acf5e3cb0e
Autor:
James G. Krueger, Wolfram Sterry, Emma Guttman-Yassky, Hiroshi Mitsui, Irma Cardinale, Mayte Suárez-Fariñas, Markus Möbs, Juana Gonzalez, Nicholas Gulati, Daniel Humme, Hanako Ohmatsu
PDF file - 54K, Primers and probes used for Quantitative RT-PCR assay.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4db4b167b0bcc06b5da131cfeef56da7
https://doi.org/10.1158/2326-6066.22537861.v1
https://doi.org/10.1158/2326-6066.22537861.v1
Autor:
Jörg Schrader, Ansgar W. Lohse, Jakob R. Izbicki, Maximillian Bockhorn, Daniel Perez, Corinna Eggers, Martina Fahl, Bence Sipos, Jan Dieckhoff, Markus Möbs, Patricia Grabowski, Martin Anlauf, Felix R. Stahl, Susanne Burdak-Rothkamm, Gerrit Wolters-Eisfeld, Victoria Weissmann, Ludmilla Unrau, Yasmin Behrang, Daniel Benten
Neuroendocrine Phenotype and mutational status NT-3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a145119b5799c888c609d56c132e3913
https://doi.org/10.1158/1541-7786.22516795.v1
https://doi.org/10.1158/1541-7786.22516795.v1
Data from Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model
Autor:
Jörg Schrader, Ansgar W. Lohse, Jakob R. Izbicki, Maximillian Bockhorn, Daniel Perez, Corinna Eggers, Martina Fahl, Bence Sipos, Jan Dieckhoff, Markus Möbs, Patricia Grabowski, Martin Anlauf, Felix R. Stahl, Susanne Burdak-Rothkamm, Gerrit Wolters-Eisfeld, Victoria Weissmann, Ludmilla Unrau, Yasmin Behrang, Daniel Benten
Clinical options for systemic therapy of neuroendocrine tumors (NET) are limited. Development of new drugs requires suitable representative in vitro and in vivo model systems. So far, the unavailability of a human model with a well-differentiated phe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03c6d542614a5bfff10ae563162a6bfa
https://doi.org/10.1158/1541-7786.c.6541486
https://doi.org/10.1158/1541-7786.c.6541486
Autor:
James G. Krueger, Wolfram Sterry, Emma Guttman-Yassky, Hiroshi Mitsui, Irma Cardinale, Mayte Suárez-Fariñas, Markus Möbs, Juana Gonzalez, Nicholas Gulati, Daniel Humme, Hanako Ohmatsu
PDF file - 53K, Selected upregulated canonical Pathways in IL-32 treated MyLa cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a354660384823e63fca147bfda5ac3a8
https://doi.org/10.1158/2326-6066.22537855
https://doi.org/10.1158/2326-6066.22537855
Autor:
James G. Krueger, Wolfram Sterry, Emma Guttman-Yassky, Hiroshi Mitsui, Irma Cardinale, Mayte Suárez-Fariñas, Markus Möbs, Juana Gonzalez, Nicholas Gulati, Daniel Humme, Hanako Ohmatsu
PDF file - 316K, Selected upregulated and down regulated genes of IL-32 treated MyLa and HH cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::157fb0d91b98d5ca42008a747af0d2e2
https://doi.org/10.1158/2326-6066.22537858
https://doi.org/10.1158/2326-6066.22537858
Autor:
Jörg Schrader, Ansgar W. Lohse, Jakob R. Izbicki, Maximillian Bockhorn, Daniel Perez, Corinna Eggers, Martina Fahl, Bence Sipos, Jan Dieckhoff, Markus Möbs, Patricia Grabowski, Martin Anlauf, Felix R. Stahl, Susanne Burdak-Rothkamm, Gerrit Wolters-Eisfeld, Victoria Weissmann, Ludmilla Unrau, Yasmin Behrang, Daniel Benten
Supplementary Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bdbd82b5c8c6d072de43793288c4626
https://doi.org/10.1158/1541-7786.22516777.v1
https://doi.org/10.1158/1541-7786.22516777.v1
Autor:
Carsten Denkert, Michael Untch, Valentina Nekljudova, Marion van Mackelenbergh, Michael Hummel, Christian Schem, Peter A. Fasching, Andreas Schneeweiss, Christine Sers, Christian Jackisch, Markus Möbs, Gunter von Minckwitz, Nicole Pfarr, Thomas Karn, Frederick Klauschen, Jenny Furlanetto, Paul Jank, Wilko Weichert, Wolfgang D. Schmitt, Albrecht Stenzinger, Karsten Weber, Jan Budczies, Denise Treue, Sibylle Loibl
Purpose:Next-generation sequencing (NGS) can be used for comprehensive investigation of molecular events in breast cancer. We evaluated the relevance of genomic alterations for response to neoadjuvant chemotherapy (NACT) in the GeparSepto trial.Exper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b46b1d3d6790e587883119c2516ed35
https://doi.org/10.1158/1078-0432.c.6527817.v1
https://doi.org/10.1158/1078-0432.c.6527817.v1